Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Combination LASIK Corneal Cross-Linking Associated With Better Outcomes
  • Refractive Surgery/Vision Correction

Combination LASIK Corneal Cross-Linking Associated With Better Outcomes

Ophthalmology 360
Combination LASIK Corneal Cross-Linking Associated With Better Outcomes

The combination of LASIK and corneal cross-linking (CXL) for the treatment of high myopia showed better predictability, stability, and less regression than LASIK alone, according to a study presented by Li Lim, MD, adjunct associate professor and senior consultant, Corneal & External Eye Disease Department, Singapore National Eye Centre, Singapore at the 2019 ASCRS-ASOA annual meeting.

This retrospective study included 85 patients (163 eyes) treated with combination LASIK-CXL at the Singapore National Eye Centre from 2013-2017. Patients had a mean age of 29 years (range: 21 to 46 years) and most were female. Mean preoperative spherical equivalent (SE) was -8.60 D (range: -4.75 to -11.75 D) and mean attempted correction was -8.84 D (range: -5.25 to -11.88 D). Patients were followed for up to 3 years, with outcome data available for 67 eyes seen at 1 year, 54 eyes seen at 2 years, and 32 eyes seen at 3 years.

At 1-year follow-up, mean SE was 0.14 D, 0.02 D at 2 years, and -0.07 D at 3 years. Good refractive stability was seen at 2- and 3-year follow-up. Approximately 70% of eyes achieved uncorrected visual acuity (UCVA) of 20/20 or better at all follow-up intervals according to the efficacy analysis.

The efficacy index, calculated as the quotient of postop UCVA/preop best corrected visual acuity (BCVA), was 0.95, 0.96, and 0.92 at 1 year, 2 years, and 3 years, respectively.

At all follow-up intervals the safety index (postop BCVA/preop BCVA) was ≥1.10 and no eyes lost more than 2 lines of BCVA. In approximately 95% of eyes, BCVA was the same or better than the preoperative BCVA at 1- and 2-year follow-up. At 3-year follow-up it was 100%.

Reference:

Presented at: ASCRS-ASOA annual meeting; May 3-7, 2019; San Diego, CA.

Share

Related Content

  • Refractive Surgery/Vision Correction

VISUMAX 800 lenticule extraction linked to high satisfaction and spectacle independence

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

  • Retina

Switching to aflibercept 8 mg extends treatment intervals in suboptimal nARMD responders

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon